NIMC
UTHR icon

NWQ Investment Management Company’s United Therapeutics UTHR Stock Holding History

NWQ Investment Management Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$4.31M Buy
42,712
+1,075
+3% +$118K 0.19% 114
2020
Q2 		$5.04K Sell
41,637
-37,052
-47% -$4.17M 0.17% 109
2020
Q1 		$7.46M Buy
+78,689
New +$7.48M 0.3% 104

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

NWQ Investment Management Company's UTHR Position: Q3 2020 in Review

NWQ Investment Management Company increased its United Therapeutics (UTHR) stake by 2.6% in Q3 2020, buying an estimated $118K and bringing the position to 42,712 shares worth $4.31M. The position accounts for 0.19% of the portfolio, ranked #114.

NWQ Investment Management Company first reported a position in UTHR in Q1 2020 and has held it in 3 quarters since. The position peaked at $7.46M in Q1 2020. 333 funds tracked by Wall St. Rank hold UTHR as of Q3 2020.

  • NWQ Investment Management Company held 42,712 shares of United Therapeutics worth $4.31M as of Q3 2020.
  • NWQ Investment Management Company bought 1,075 United Therapeutics shares in Q3 2020, an estimated $118K.
  • United Therapeutics made up 0.19% of NWQ Investment Management Company's portfolio in Q3 2020, its #114 holding.
  • NWQ Investment Management Company first reported a position in United Therapeutics in Q1 2020 and has held it in 3 quarters since.
  • NWQ Investment Management Company's United Therapeutics position peaked at $7.46M in Q1 2020.
  • 333 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.